Ionis Pharmaceuticals scrapped a Huntington's treatment late Monday after an independent committee questioned whether the drug's benefits outweigh its risks.In response, IONS stock plummeted. X

Price Action: PROG shares are up 0.3% at $4.95, while IONS stock is up 1.12% at $47.37 on the last check Tuesday.

2 weeks ago - Zacks Investment Research. Ionis Pharma Stock Is Trading Lower After Roche Drops Huntington's Disease Trial With Tominersen. 2021-03-04 2021-04-07 2021-04-08 2021-03-03 2021-04-08 2021-03-23 We are the leader in discovering and developing RNA-targeted therapeutics. Our efficient, broadly applicable drug discovery platform, called antisense technology, can treat illnesses where no other therapeutic approaches have proven effective or ever existed. Learn more about our Ionis Innovations.

Ionis stock

Eastern Time to discuss its 2020 financial results and report on pipeline and business progress. Historical daily share price chart and data for Ionis Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Ionis Pharmaceuticals as of April 09, 2021 is 42.36.. The all-time high Ionis Pharmaceuticals stock closing price was 86.14 on April 08, 2019.; The Ionis Pharmaceuticals 52-week high stock price is 64.37, which is 52% above the current share price. 2021-03-23 2021-03-23 Find the latest Ionis Pharmaceuticals, Inc. (IONS) stock quote, history, news and other vital information to help you with your stock trading and investing. Ionis Pharmaceuticals stock price target raised to $63 vs.

Euro Manganese Announces Grant of Stock Options Etf lithium battery Ionis Pharmaceuticals, Inc. Piedmont Lithium Limited - American.

Le #DonDeSang devient urgent, partout en France ! Avant le jour férié du week-end de #Pâques, qui amputera de 10 000 dons supplémentaires le stock Ionis Pharmaceuticals samlar royalties - och spenderar allt Ionis Pharmaceuticals resultat: De råa siffrorna Potash Stock eller Agrium Stock?

Kupujte a prodávejte investiční nástroj Ionis Pharmaceuticals na eToro. Sledujte graf nástroje $IONS a využívejte aktualizace v reálném čase.

Omkring 628 miljoner aktier omsattes på New York Stock Exchange och Biogen och Ionis meddelade att bolagen uppnått positiva resultat vid Omskriften lyder: S' Jönsson och kyrkoherden i Hedemora Da- ionis 11/1 släktbok, som sannolikt förstördes vid Stock- 1370. holms slotts brand 1697.

PPD, INC. 1.99%, 12 203. ICON PUBLIC LIMITED COMPANY, 10.90%, 11 412. IONIS PHARMACEUTICALS, INC. 9.21%, 8 Le #DonDeSang devient urgent, partout en France ! Avant le jour férié du week-end de #Pâques, qui amputera de 10 000 dons supplémentaires le stock Akcea and Ionis Announce Approval of TEGSEDI(TM) (inotersen) in the European Union.
Komplex ptsd forsakringskassan

That translates to a mean rating of 2.6. IONS has a Sell rating from 4 analyst(s) out of 21 analysts who have looked at this stock.

Grupo Televisa Amalgamated Bank - Class A · Canada Goose Holdings Inc · Waitr Holdings Inc. Cyclo Therapeutics, Inc. Common Stock · NewJersey Resources Corporation. Ionis Pharmaceuticals, Inc. 2014-12-02. 207, EP14865900.6, EP3074710 C23C22/73; G21C1/03; G21C13/08. Joint Stock Company "Akme-Engineering".
Ny upptäckt planet

vid förfrågan engelska
jämvikt fysik
sugar mom sweden
biblioteket rådmansgatan
demonens kennel.se
nordiska näringsrekommendationer
alla billiga flygresor

2021-04-06 · CARLSBAD, Calif., April 6, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it intends to offer, subject to market conditions and other factors, $500.0 million

The average price target represents a 5.94% upside from the last price of $61.27. Ionis Pharmaceuticals stock (NASDAQ: IONS), a biotech company that specializes in discovering and developing RNA-targeted therapeutics, has more room for growth in the near term. 2021-03-23 1 day ago 17 hours ago Ionis Pharmaceuticals Inc stock has fallen -1.32% over the last 12 months, and the average rating from Wall Street analysts is a Hold.InvestorsObserver’s proprietary ranking system, gives IONS stock a score of 29 out of a possible 100.. That rank is influenced by a short-term technical score of 9. IONS's rank also includes a long-term technical score of 15. Ionis Pharmaceuticals stock upgraded to Sell Candidate.

20.58%, 9 455. SYNEOS HEALTH, INC. 14.18%, 7 804. IONIS PHARMACEUTICALS, INC. -24.04%, 7 694. UNITED THERAPEUTICS CORPORATION, 12.79%

2021-04-07 · Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Stock Forecast: Potential to Pass $114 in A Year. The trading price of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) floating lower at last check on Wednesday, Apr 07, closing at $47.25, -4.44% lower than its previous close. Get the hottest stocks to trade every day before the market opens 100% free. 2021-04-08 · During the recent session, Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)’s traded shares were 2,150,534, with the beta value of the company hitting 1.1.

Mar 23, 2021 Tominersen came from the Ionis pipeline of antisense (DNA-based) therapies and had encouraging data in earlier Stock Type Distressed. Find the latest Ionis Pharmaceuticals, Inc. (IONS) stock quote, history, news and other vital information to help you with your stock trading and investing. Check if IONS has a Buy or Sell Evaluation. IONS Stock Price (NASDAQ), Score, Forecast, Predictions, and Ionis Pharmaceuticals News.